Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
magnesium chloride + potassium chloride + sodium gluconate + sodium acetate + sodium chloride is a sterile, nonpyrogenic, isotonic balanced electrolyte solution used primarily for intravenous fluid and electrolyte replacement and, in some product presentations, for general irrigation, washing, and rinsing. Marketed under brands including Plasma-Lyte A, Plasma-Lyte 148, and Physiolyte, it is manufactured by companies such as Baxter and B. Braun. The formulation contains inorganic electrolyte salts that replenish sodium, potassium, magnesium, and chloride, while acetate and gluconate are metabolized to bicarbonate precursors and provide an alkalinizing effect. With a near-physiologic pH and osmolarity approximating plasma, it is used in adults and pediatric patients as a source of water and electrolytes, for dehydration and electrolyte imbalance, and as an alkalinizing agent.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on magnesium chloride + potassium chloride + sodium gluconate + sodium acetate + sodium chloride.